StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the stock.
China Pharma Price Performance
CPHI stock traded down $0.01 during midday trading on Thursday, reaching $0.18. 184,586 shares of the company’s stock traded hands, compared to its average volume of 368,103. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.16. The firm’s fifty day moving average price is $0.23 and its 200-day moving average price is $0.25. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative return on equity of 61.46% and a negative net margin of 85.56%. The business had revenue of $0.93 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Top-Performing Non-Leveraged ETFs This Year
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
